> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel Meeting on Durect NDA for Bupivacaine
- URL: https://www.fdaweb.com/panel-meeting-on-durect-nda-for-bupivacaine/
- Published: 2019-11-20T12:00:00.000Z
- Updated: 2026-09-14T15:53:46.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145554

*Federal Register* notice: FDA has announced a 1/16 Anesthetic and Analgesic Drug Products Advisory Committee meeting. Panel members will discuss a Durect NDA for bupivacaine extended-release solution for instillation for treating post-surgical analgesia. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2019-25278.pdf?ref=fdaweb.com).